Results 31 to 40 of about 33,029 (292)

Intravascular Large B-Cell Lymphoma Presenting as Dementia and Hemolytic Anemia [PDF]

, 2010
Background: Intravascular lymphoma (IVL) is an uncommon disease characterized by atypical lymphoid cells growing inside the lumina of small vessels. The diversity of clinical presentation due to possible involvement of multiple organs often complicates ...
Ahle, Guido, Baraniskin, Alexander, Jähnert, Andreas, Kretzschmar, Hans, Schmiegel, Wolff, Schroers, Roland, Theile, Anja   +6 more
core   +1 more source

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation [PDF]

, 2006
Objective: Heavy post-transplant immunosuppression may contribute to long-term immunosuppression dependence by subverting tolerogenic mechanisms; thus, we sought to determine if this undesirable consequence could be mitigated by pretransplant lymphoid ...
Abhay N. Vats, Adrianna Zeevi, Akhtar S. Khan, Amadeo Marcos, Amit Basu, Bartosh, Calne, Calne, Chakrabarti, Corde McFeaters, Demetrius Ellis, Edward A. Gray, Fine, Gerri James, Halloran, Henkie P. Tan, Jensen, Kirk, Knechtle, Lilly, Mary Jo Grosso, McCurry, Michael L. Moritz, Mueller, Najarian, Nankivell, Purighalla, Randhawa, Reyes, Riley, Ron Shapiro, Sarwal, Shapiro, Shapiro, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Starzl, Stuart, Thomas E. Starzl, Todo, Waldmann, Williams   +52 more
core   +1 more source

Cold Agglutinin-induced Hemolytic Anemia as the Primary Presentation in Systematic Lupus Erythematosus (SLE) in Pregnancy Triggered by Infection: A Case Report

Case Reports in Clinical Practice, 2022
Autoimmune hemolytic anemia (AIHA) may be the first manifestation of systematic lupus erythematosus (SLE). Antierythrocyte antibodies in SLE are mainly warm-type Immunoglobulin G (IgG), but mixed-type AIHA is also reported.
Vajihe Marsusi, Ashraf Sadat Jamal, Laleh Eslamian, Maasoumeh Saleh, Behnaz Nouri, Danial Dehghan   +5 more
doaj  

Non-immune Hemolysis in Gaucher Disease and Review of the Literature Eliyakim Hershkop, Idan Bergman, Alina Kurolap, Najib Dally, and Hagit Baris Feld

Rambam Maimonides Medical Journal, 2021
Gaucher disease (GD) is an autosomal recessive disease characterized by the buildup of glucocerebrosides in macrophages, resulting in the formation of “Gaucher cells.” These cells predominantly infiltrate the liver, spleen, and bone marrow leading to ...
Eliyakim Hershkop, Idan Bergman, Alina Kurolap, Najib Dally, Hagit Baris Feldman   +4 more
doaj   +1 more source

Sublytic Terminal Complement Components Induce Eryptosis in Autoimmune Haemolytic Anaemia Related to IgM Autoantibodies [PDF]

, 2019
BACKGROUND/AIMS: Eryptosis, the suicidal death of red blood cells (RBCs), is characterized by phosphatidylserine (PS) exposure at the cell surface. It can be catalysed by a variety of abnormal conditions and diseases.
Balola, Abdelwahab Hassan Ahmed, Bartolmäs, Thilo, Mayer, Beate, Salama, Abdulgabar   +3 more
core   +1 more source

Hemolytic Anemias: Autoimmune and Beyond

Journal of the Advanced Practitioner in Oncology, 2021
During JADPRO Live Virtual 2020, Ravi Krishnadasan, MD, FACP, provided an overview of the terminology of hemolysis, laboratory tests used in the diagnosis of hemolytic anemias, and appropriate indications for treatment of the various hemolytic anemias.
openaire   +4 more sources

Vitamin B12 and vitamin D deficiencies: An unusual cause of fever, severe hemolytic anemia and thrombocytopenia

Journal of Family Medicine and Primary Care, 2015
The array of diagnostic workup for pyrexia of unknown origin (PUO) generally revolves in searching for infections, inflammatory/autoimmune, and endocrine etiologies.
Vikas A Mishra, Rishit Harbada, Akhilesh Sharma   +2 more
doaj   +1 more source

Development of New Drugs for Autoimmune Hemolytic Anemia

Pharmaceutics, 2022
Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the autoantibody-mediated destruction of red blood cells, and treatments for it still remain challenging.
Zhengrui Xiao, Irina Murakhovskaya
doaj   +1 more source

Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia [PDF]

, 2016
Immune-mediated haemolytic anaemia (IMHA) is reported to be the most common autoimmune disease of dogs, resulting in significant morbidity and mortality in affected animals.
A Corato, A Doganci, A Knueppel, A Kojima, A Mqadmi, A Saxena, A Zanella, AL Rivas, AM Hall, AM Hall, B Sadlack, Barbara Glanemann, CA Lawson, CJ Elson, CJ Piek, CL Bennett, D Cao, D Pinheiro, DM Willerford, Douglas Thamm, E Ahmad, E Fagiolo, E Fagiolo, E Fagiolo, E Fagiolo, E von Elm, FJ Ward, G Kleiner, HF Titmarsh, James W. Swann, JH Buckner, JM Kim, JS Ellis, JW Swann, K Wing, KD Mitchell, Kelly Woods, KY King, L Han, L Llorente, L Llorente, L Xu, M Kjelgaard-Hansen, M Miyara, M Murai, MA Miller, ME Brunkow, NJ Davidson, NV Giltiay, OA Garden, Oliver A. Garden, P Pietschmann, PM McManus, RN Barker, RS Wildin, S Aggarwal, S Berentsen, S Lindley, S McCullough, S Sakaguchi, SA Bustin, SJ Ireland, V Viglietta, X Valencia, Ying Wu, Z Jiao   +65 more
core   +5 more sources

Bortezomib in autoimmune hemolytic anemia and beyond [PDF]

Therapeutic Advances in Hematology, 2021
Bortezomib is a first-in-class, potent, selective and reversible proteasome inhibitor approved for the treatment of multiple myeloma (MM) and relapsed/refractory mantle cell lymphoma. In these diseases, bortezomib targets plasma cells and lymphocytes reducing tumor burden.
Pasquale R., Giannotta J. A., Barcellini W., Fattizzo B.   +3 more
openaire   +4 more sources